PureHealth reported solid first-quarter 2026 results, supported by sustained demand across its core markets and rising contributions from its international portfolio. Moreover, the performance reinforced the Group’s strategy of geographic diversification.
Revenue increased 10% year-on-year to AED 7.3 billion ($2 billion), driven by growth in its international Care portfolio and the Cover insurance vertical. Additionally, EBITDA rose 5% to AED 1.2 billion ($327 million), reflecting continued expansion across global markets and the strength of the operating model.
Net profit reached AED 415 million ($113 million) in Q1 2026. However, the result reflected the impact of regulatory developments under the Unified Purchasing Programme during the period.
Management Highlights Global Expansion Momentum
Kamal Al Maazmi, Chairman of PureHealth, said: “PureHealth delivered a strong start to 2026, with robust growth across the Group reflecting sustained demand and disciplined execution. Our performance continues to be driven by the scale and resilience of our integrated Care and Cover model, which provides both stability and long-term growth opportunities.
“The continued momentum in our international portfolio has played an increasingly important role in the Group’s growth and diversification, while complementing our leadership position in the UAE.
“As we move forward, we remain focused on advancing our strategy and reinforcing PureHealth’s position as a leading global healthcare platform.”
Shaista Asif, Group CEO of PureHealth, said: “Our first-quarter performance reflects resilience across our core markets and the growing momentum of our international portfolio. Circle Health and Hellenic Healthcare Group delivered solid performances, significantly scaling our international revenue base and further reinforcing the strategic rationale for our global expansion.
“In the UAE, we continued to expand capacity, deepen clinical complexity, and grow our insurance platform, reflecting the sustained underlying strength of our home market. We continue to build on the strength of our integrated platform, accelerating clinical excellence, advancing our global expansion, and further strengthening our position as a leading international healthcare group.”
Outlook Focused on Scale and Higher-Margin Growth
Looking ahead, PureHealth said it remains well positioned to deliver sustainable growth. Additionally, the Group expects further expansion and integration of its international platform to support medium-term revenue diversification.
The company also expects its high-margin international portfolio to play a larger role in driving performance. Moreover, recently acquired assets are expected to continue scaling and generating operational synergies.
At the same time, the Group plans to continue investing in capacity expansion, service complexity, and high-acuity care. Furthermore, it aims to accelerate digital and AI-enabled initiatives to enhance operational efficiency and patient experience.
